Quantcast

Tag Archives: Vytorin

Merck settles Vytorin shareholder class action suit

Merck will pay $5.1 million in attorney fees and institute corporate reforms under the terms of a settlement of a shareholder class action concerning the alleged suppression of negative clinical test results for the blockbuster anti-cholesterol drug Vytorin.

Read More »

Drugmakers pay $41.5 million to settle Vytorin suits

Merck & Co. and Schering-Plough Corp. said yesterday they will pay $41.5 million to settle lawsuits involving their cholesterol medication Vytorin. The suits claimed the drug makers violated state consumer protection laws by delaying unfavorable study results because they would ...

Read More »